Annovis Bio, Inc. (ANVS)
1.70
+0.01
(+0.59%)
USD |
NYSE |
Sep 02, 16:00
1.64
-0.06
(-3.53%)
Pre-Market: 06:49
Annovis Bio Total Liabilities (Quarterly) : 26.29M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.29M |
| March 31, 2026 | 13.12M |
| December 31, 2025 | 4.230M |
| September 30, 2025 | 4.033M |
| June 30, 2025 | 3.124M |
| March 31, 2025 | 2.683M |
| December 31, 2024 | 4.618M |
| September 30, 2024 | 7.298M |
| June 30, 2024 | 6.797M |
| March 31, 2024 | 11.17M |
| December 31, 2023 | 17.96M |
| September 30, 2023 | 3.565M |
| June 30, 2023 | 2.074M |
| March 31, 2023 | 5.411M |
| December 31, 2022 | 7.698M |
| September 30, 2022 | 2.526M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.299M |
| March 31, 2022 | 1.256M |
| December 31, 2021 | 1.506M |
| September 30, 2021 | 1.121M |
| June 30, 2021 | 0.8841M |
| March 31, 2021 | 1.597M |
| December 31, 2020 | 0.5784M |
| September 30, 2020 | 0.2811M |
| June 30, 2020 | 0.7029M |
| March 31, 2020 | 0.7493M |
| December 31, 2019 | 2.617M |
| September 30, 2019 | 1.678M |
| June 30, 2019 | 1.344M |
| March 31, 2019 | 1.130M |
| December 31, 2018 | 0.5679M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.04M |
| Shareholders Equity (Quarterly) | -4.255M |
| Current Ratio | 3.466 |